^
BIOMARKER:
MSI-H/dMMR
i
Other names: MSI-H, Microsatellite instability - high, dMMR
MSI-H/dMMR
Endometrial Cancer
dostarlimab
Sensitive
:
A1
AnaptysBio Press Release - 2wk
MSI-H/dMMR
Small Intestinal Carcinoma
pembrolizumab
Sensitive
:
A2
Clin Cancer Res - 2wk
MSI-H/dMMR
Neuroendocrine Tumor
pembrolizumab
Sensitive
:
A2
NCCN - 3wk
MSI-H/dMMR
CRC
pembrolizumab
Sensitive
:
A1
MSI-H/dMMR
CRC
nivolumab + ipilimumab
Sensitive
:
A1
MSI-H/dMMR
Solid Tumor
pembrolizumab
Sensitive
:
A1
MSI-H/dMMR
CRC
nivolumab
Sensitive
:
A1
MSI-H/dMMR
Peritoneal Cancer
pembrolizumab
Sensitive
:
A2
MSI-H/dMMR
Colon Cancer
CAPOX
Sensitive
:
A2
MSI-H/dMMR
Colon Cancer
FOLFOX
Sensitive
:
A2
MSI-H/dMMR
Prostate Cancer
pembrolizumab
Sensitive
:
A2
MSI-H/dMMR
Fallopian Tube Cancer
pembrolizumab
Sensitive
:
A2
MSI-H/dMMR
Maxillary Sinus Carcinoma
pembrolizumab
Sensitive
:
A2
MSI-H/dMMR
Penile Cancer
pembrolizumab
Sensitive
:
A2
MSI-H/dMMR
Small Intestinal Carcinoma
nivolumab
Sensitive
:
A2
MSI-H/dMMR
Small Intestinal Carcinoma
pembrolizumab + ipilimumab
Sensitive
:
A2
MSI-H/dMMR
Small Intestinal Carcinoma
nivolumab + ipilimumab
Sensitive
:
A2
MSI-H/dMMR
Ovarian Cancer
pembrolizumab
Sensitive
:
A2
MSI-H/dMMR
Germ Cell Tumors
pembrolizumab
Sensitive
:
A2
MSI-H/dMMR
Gastroesophageal Junction Adenocarcinoma
pembrolizumab
Sensitive
:
A2
MSI-H/dMMR
Biliary Tract Cancer
pembrolizumab
Sensitive
:
A2
MSI-H/dMMR
Endometrial Cancer
pembrolizumab
Sensitive
:
A2
MSI-H/dMMR
Gastric Cancer
pembrolizumab
Sensitive
:
A2
MSI-H/dMMR
Pancreatic Adenocarcinoma
pembrolizumab
Sensitive
:
A2
MSI-H/dMMR
Cervical Cancer
pembrolizumab
Sensitive
:
A2
MSI-H/dMMR
Chordoma
pembrolizumab
Sensitive
:
A2
MSI-H/dMMR
Ewing Sarcoma
pembrolizumab
Sensitive
:
A2
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our